This opportunity funds research to overcome challenges in developing therapies for ultra-rare cancers, focusing on pediatric and adult cases. It supports projects developing coordination networks, validating novel clinical endpoints, leveraging real-world data, repurposing drugs, and advancing nanoparticle delivery and molecular characterization techniques to accelerate treatment innovation.
Eligible applicants include city or township governments, small businesses, tribal organizations, public and private higher education institutions, for-profit organizations, independent school districts, county and state governments, public housing authorities, and nonprofits with or without 501(c)(
